Last update:
Oncology news
Lung cancer drug offers a surprising new treatment against ovarian cancer
A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this class of drugs work better. ...
12 hours ago
0
0
Unraveling the mystery of why some cancer treatments stop working
Cancer researchers working on immunotherapies have made a big discovery: SLAMF6, a molecule on the surface of immune cells that prevents T cells from effectively attacking tumors—and, in mice, they've found a way to neutralize ...
15 hours ago
0
0
Light-based sensor detects early molecular signs of cancer in the blood
Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the blood. The new technology could one day make it possible to spot early signs of cancer ...
17 hours ago
0
1
New characteristics of aggressive prostate cancer identified
For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through ...
11 hours ago
0
0
Best diagnostic test for ovarian cancer in premenopausal women identified
Premenopausal women would benefit from a significantly more accurate diagnostic pathway for ovarian cancer, as a new study finds that an advanced ultrasound test, IOTA ADNEX, identified 9 out of 10 cancers in women who took ...
12 hours ago
0
0
Genetic risk may rival obesity as a key driver of endometrial cancer
A major new study has found genetics play a powerful and independent role in endometrial cancer risk—challenging the long-held belief that obesity is the primary driver. The findings could lead to better screening of the ...
12 hours ago
0
0
Rallying more T-cells to immunotherapy's fight against cancer
Immune Checkpoint Blockade (ICB) has revolutionized the treatment of cancers like melanoma, but up to 60% of patients don't respond to this immunotherapy for reasons not yet fully understood. Australian scientists have found ...
12 hours ago
0
0
Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer
Seventy-five percent of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) who were treated with the antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) had a complete response, according to new data from ...
13 hours ago
0
0
Colorectal cancer is rising in younger adults. Here's who is most at risk and symptoms to watch for
Colorectal cancer is a threat not just to older adults but increasingly to young men and women, too. It's now the top cancer killer of Americans younger than 50.
9 hours ago
0
0
Researchers develop metastasis prevention therapy based on glycan targeting
A research team led by Prof. Kenward Vong, Assistant Professor from the Department of Chemistry at The Hong Kong University of Science and Technology (HKUST) has recently achieved a significant breakthrough by bioengineering ...
9 hours ago
0
0
Pancreatic cancer: Warning signs to heed
Your pancreas has important jobs to do. A large gland behind the lower part of the stomach, it produces hormones that regulate blood sugar and enzymes that help digest food. What if it develops cancer?
7 hours ago
0
0
Study strengthens evidence supporting lung-sparing surgery, offering hope for mesothelioma patients
A new study from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds that pleurectomy/decortication, a lung-sparing surgery, can be performed safely with low mortality in carefully selected ...
14 hours ago
0
0
New research results in changes to NHS guidelines
Hundreds of people with advanced bladder cancer across the UK can now receive three rather than six chemotherapy cycles following research by Queen Mary University of London which has led to a change to NHS treatment guidelines. ...
21 hours ago
0
0
A single oncolytic virus injection may help T cells infiltrate glioblastoma
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and destroys cancer cells—can ...
Feb 11, 2026
0
80
New AI tool helps scientists see how cells work together inside diseased tissue
Doctors and scientists have long relied on microscopes to study human tissue and diagnose disease. But today's medical research produces far more information than the human eye alone can handle, including detailed maps of ...
Feb 11, 2026
0
0
HPV cancer vaccine slows tumor growth and extends survival in preclinical model
Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not only on vaccine components but also on vaccine structure. After proving this concept ...
Feb 11, 2026
0
13
Doctors discover a simple method to predict the risk of brain tumor recurrence
Meningioma is the most common type of brain tumor. It does not develop in the brain tissue itself, but on the inside of the meninges, the membranes that surround the brain. In most cases, a meningioma is benign. However, ...
Feb 11, 2026
0
0
Tiny worm offers clues to combat chemotherapy neurotoxicity
Chemotherapy remains one of the most powerful tools in the fight against cancer, yet it often comes with significant long-term side effects that can dramatically affect patients' quality of life. Among the most debilitating ...
Feb 11, 2026
0
45
Aggressive brain tumors build protective 'sugar shield' to survive extreme stress
For the first time, researchers have identified a previously unrecognized metabolic defense mechanism in aggressive brain tumors: a sugar-rich shield that surrounds tumor cells and protects them against a particularly destructive ...
Feb 11, 2026
0
0
Established cancer drug can reactivate immunotherapy
Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune cells recognize gradually ...
Feb 11, 2026
0
0
Key gene behind drug resistance in small cell lung cancer identified
A research team has discovered a crucial mechanism that underlies chemotherapy resistance and metastasis in small cell lung cancer (SCLC). Their study shows that the silencing of the RASA4 gene through epigenetic mechanisms ...
Feb 11, 2026
0
0
Experimental drug may protect the brain against depression and cognitive impairment caused by whole brain radiotherapy
Whole brain radiotherapy (WBRT) saves lives by treating cancer that has spread to the brain, but it also causes long-standing brain damage. Many patients who go through radiation treatment later develop memory problems, thinking ...
Feb 11, 2026
0
0
Molecule found to drive skin cancer growth and evade immune detection
A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors' ability to evade attack by the body's immune system, a new study shows. Led by researchers at NYU Langone Health and ...
Feb 11, 2026
0
0
Review calls for risk-based screening as never-smoker lung cancers rise
Lung cancer patients who have never smoked make up a significant and growing share of global lung cancer cases, yet remain an understudied group, according to a new review written by UCL (University College London) researchers.
Feb 11, 2026
0
0
